Yüklüyor......
SAT-621 An Atypical Case of Nivolumab-Induced Thyroiditis with Persistently Elevated Thyroid-Stimulating Immunoglobulin
BACKGROUND: The anti-PD1 monoclonal antibody nivolumab, approved for treatment of several cancers, is associated with ~ 3% rate of hyperthyroidism. Most cases are due to destructive thyroiditis. Stimulating antibodies against the TSH receptor (TSH-R) have not been reported in nivolumab-associated th...
Kaydedildi:
| Yayımlandı: | J Endocr Soc |
|---|---|
| Yazar: | |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Endocrine Society
2019
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6552309/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/js.2019-SAT-621 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|